Topotecan 387 - An open-label,randomised, phase 3 study comparing oral Topotecan to intravenous Docetaxel in patients with pre-treated advanced non-small cell lung cancer

  • James, Paul (Primary Chief Investigator (PCI))
  • Leyden, Michael (Chief Investigator (CI))
  • Narayan, Kam (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date11/10/0231/12/03